Concepedia
Statistics
Publications
6
Citations
368
H-Index
Active since
2005
Affiliations
University of Alabama at Birmingham(Current)
Lymphoma Research Foundation
Ronda Carlisle is an author at University of Alabama at Birmingham specializing in immunology, immunotherapy, and medicine.
Top concepts
MedicineImmunologyImmunotherapyOncologyPathologyInflammationTumor ImmunityImmunosuppressionRadiation OncologyImmune Surveillance
Publications per year
2005–2010
Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
Andres Forero‐Torres, Jatin J. Shah, Tina E. Wood et al. · Cancer Biotherapy and Radiopharmaceuticals · 2010 · 141 citations · Full text
Phase I Study of a Plasmid DNA Vaccine Encoding MART-1 in Patients with Resected Melanoma at Risk for Relapse
Pierre L. Triozzi, Wayne Aldrich, Karen O. Allen et al. · Journal of Immunotherapy · 2005 · 52 citations
Hbsag Antigen, Cancer Immunosurveillance, Hbsag Plasmid +15
Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas
James Posey, Muhammad Wasif Saif, Ronda Carlisle et al. · Clinical Cancer Research · 2005 · 51 citations
Phase I Study of the Intratumoral Administration of Recombinant Canarypox Viruses Expressing B7.1 and Interleukin 12 in Patients with Metastatic Melanoma
Pierre L. Triozzi, Karen O. Allen, Ronda Carlisle et al. · Clinical Cancer Research · 2005 · 51 citations
Immunology, Immunoediting, Pathology +19
Intratumoral Administration of a Recombinant Canarypox Virus Expressing Interleukin 12 in Patients with Metastatic Melanoma
Pierre L. Triozzi, Theresa V. Strong, R. Pat Bucy et al. · Human Gene Therapy · 2005 · 45 citations
Immunology, Immunotherapeutics, Dermatology +17
1–5 of 6